The Swiss firm touts Drom’s creative flair and intimate regional and local customer connections in its 24 July acquisition announcement. One week earlier, Givaudan released impressive fiscal 2019 first-half results and announced the opening of a new flagship innovation center in Zurich, Switzerland.

Back in April, CEO Noel Wallace noted Colgate’s interest in further skin-care M&A during his first quarterly presentation at the firm’s helm. The Filorga purchase is significantly bigger than 2018 deals that whet Colgate’s appetite for high-growth, high-margin skin care and represents a gateway to the fast-growing travel retail channel.

Bristol-Myers Squibb is free to focus on drug development for patients facing serious diseases, with the divestment of its UPSA consumer health business to Taisho now complete. Separately, Harvest One Cannabis and iAnthus Capital Holdings build their capabilities to meet soaring demand for CBD and other cannabis-derived health, wellness and beauty products.

Amid global recession fears, Lauder anticipates continued double-digit growth in fiscal 2020 in China and travel retail, albeit at slower rates than seen in recent years. The firm booked 9% reported sales growth to roughly $14.9bn for the fiscal 2019 full year, fueled by a record-setting innovation program.

Launches announced in August include Clarisonic Mia Men, the brand’s first cleansing device specifically engineered for men’s thicker skin and beard, and Act Of Being, touted as “America’s first 100% vegan men’s grooming and skin-care brand.” Fragrances from Ariana Grande and Vince Camuto debut, along with Moroccanoil Color Depositing Masks and Avon Products’ True 5-in-1 Lash Genius mascara.

E-commerce, Asia and travel retail continue to fuel gains at L’Oreal, which just posted its strongest first-half like-for-like growth in more than a decade. Skin care remains a key driver as well, offsetting a global slowdown in makeup that has hit the firm’s US business hardest, with little improvement expected this year.

Amid global recession fears, Lauder anticipates continued double-digit growth in fiscal 2020 in China and travel retail, albeit at slower rates than seen in recent years. The firm booked 9% reported sales growth to roughly $14.9bn for the fiscal 2019 full year, fueled by a record-setting innovation program.

E-commerce, Asia and travel retail continue to fuel gains at L’Oreal, which just posted its strongest first-half like-for-like growth in more than a decade. Skin care remains a key driver as well, offsetting a global slowdown in makeup that has hit the firm’s US business hardest, with little improvement expected this year.

CEO says higher revenues on consumer health product sales partly due to higher prices should go to innovation rather than advertising. During Q2 earnings briefing, analysts suggest competitors will boost promotions and hamper C&D’s 4% organic growth outlook for 2019.